• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

AAP issues statement on cochlear implants

Article

Children preparing for cochlear implant surgery should receive all age-appropriate doses of pneumococcal conjugate and Haemophilus influenzae type b conjugate vaccines and appropriate annual immunization against influenza at least 2 weeks before surgery, according to a recent policy statement.

Children preparing for cochlear implant surgery should receive all age-appropriate doses of pneumococcal conjugate and Haemophilus influenzae type b conjugate vaccines and appropriate annual immunization against influenza at least 2 weeks before surgery, according to a recent policy statement from the American Academy of Pediatrics published in the July 26 online issue of Pediatrics.

Cochlear implants increase the risk of acute otitis media and bacterial meningitis, especially during the first 2 months after implantation. Doctors should watch for signs of these conditions and treat immediately with a parenteral antibiotic (eg, ceftriaxione or cefotaxime).

"Watchful waiting" without antimicrobial therapy is inappropriate for children with implants with acute otitis media, according the statement. After acute otitis media develops, bacteria can enter the inner ear through an incompletely sealed cochleostomy. Patients with meningitis should be urgently evaluated by an otolaryngologist for consideration of imaging and surgical exploration.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.